Qinghai Spring Medicinal Resources Technology Co., Ltd. provided earnings guidance for 2017. According to preliminary statistics of its financial department, the company predicts that the net profit belonging to shareholders of the listed company in 2017 will increase by between RMB 45 million and RMB 90 million with an increase of between 18% and 37% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss is expected to increase by between RMB 41.6 million and RMB 84.6 million with an increase of about between 20% and 40% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations).